A Case of Mixed Connective Tissue Disease Associated with Graves' Disease

M. Erkan Kozanoğlu, İlke Coşkun Benlidayı, Murat Sert

Issue: Volume 23 - Issue 3 - June 2008
1000 7838

Retroperitoneal Fibrosis and Aortitis as the Initial Findings of Systemic Lupus Erythematosus

Aynur SOYUÖZ, Metin IŞIK, İsmail DOĞAN, Levent KILIÇ, Sedat KİRAZ

DOI: 10.5606/tjr.2011.042

Issue: Volume 26 - Issue 3 - September 2011
10353 7253

Serum Interleukin-18 Level is Associated With Disease Activity and Interstitial Lung Disease in Patients With Dermatomyositis

Yuan YANG, Geng YIN, Jingcheng HAO, Qibing XIE, Yi LIU

DOI: 10.5606/ArchRheumatol.2017.6175

Issue: Volume 32 - Issue 3 - September 2017
7731 5876

The Association of Anti-Aminoacyl-Transfer Ribonucleic Acid Synthetase Antibodies in Patients With Rheumatoid Arthritis and Interstitial Lung Disease

Masakazu MATSUSHITA, Naoto TAMURA, Michihiro OGASAWARA, Kurisu TADA, Ken YAMAJI, Yoshinari TAKASAKI

DOI: 10.5606/ArchRheumatol.2018.6401

Issue: Volume 33 - Issue 1 - March 2018
5899 6916

Value of Serum Carbohydrate Antigen 19-9 and Carcinoembryonic Antigen in Evaluating Severity and Prognosis of Connective Tissue Disease-Associated Interstitial Lung Disease

Qian JIN, Jisheng ZHENG, Xianrong XU, Yeming HU, Ying ZHOU, Weihua XU, Feihua HUANG

DOI: 10.5606/ArchRheumatol.2018.6419

Issue: Volume 33 - Issue 2 - June 2018
5978 5925

Recurrent Benign Pneumatosis Intestinalis in a Patient With Mixed Connective Tissue Disease

Sahil KOPPIKAR, David YU, Mark ROPELESKI, David ROBERTSON

DOI: 10.5606/ArchRheumatol.2018.6589

Issue: Volume 33 - Issue 4 - December 2018
3910 4966

Clinical Characteristics of Systemic Sclerosis With Interstitial Lung Disease

Eunju JUNG, Chang-hee SUH, Hyoun-ah KİM, Ju-yang JUNG

DOI: 10.5606/ArchRheumatol.2018.6630

Issue: Volume 33 - Issue 3 - September 2018
6653 5915

Tumor-Associated Antigens in Rheumatoid Arthritis Interstitial Lung Disease or Malignancy?

Gökhan SARGIN, Reyhan KÖSE, Taşkın ŞENTÜRK

DOI: 10.5606/ArchRheumatol.2018.6691

Issue: Volume 33 - Issue 4 - December 2018
5226 7723

Efficacy of Combination Therapy With Pirfenidone and Low-Dose Cyclophosphamide for Refractory Interstitial Lung Disease Associated With Connective Tissue Disease: A Case-Series of Seven Patients

Lichong SHEN, Qingran YAN, Xiaoxiang CHEN

DOI: 10.46497/ArchRheumatol.2020.7381

Issue: Volume 35 - Issue 2 - June 2020
4704 4146

Association of Interstitial Lung Disease With Clinical Characteristics of Chinese Patients With Systemic Lupus Erythematosus

Yaling CHEN, Yanqing WANG, Xiangfang CHEN, Huishun LIANG, Xuwei YANG

DOI: 10.46497/ArchRheumatol.2020.7583

Issue: Volume 35 - Issue 2 - June 2020
5412 2667

Usefulness of digital velcro crackles detection in identification of interstitial lung disease in patients with connective tissue diseases

Andreina MANFREDI, Giulia CASSONE, Caterina VACCHI, Fabrizio PANCALDI, Giovanni Della CASA, Stefania CERRI, Lisa De PASQUALE, Fabrizio LUPPI, Carlo SALVARANI, Marco SEBASTIANI

DOI: 10.46497/ArchRheumatol.2021.7975

Issue: Volume 36 - Issue 1 - March 2021
4973 2798

Clinical and serological characteristics of systemic sclerosis: Experience of a tertiary care center in Pakistan

Sadia Asif, Asadullah Khan, Muhammad Faiq, Zia Ud Din, Sarmad Zahoor, Muhammad Haroon

DOI: 10.46497/ArchRheumatol.2021.8701

Issue: Volume 36 - Issue 4 - December 2021
3478 2630

The impact of COVID-19 on clinical course and treatment among patients with juvenile systemic sclerosis

Amra Adrovic, Mehmet Yıldız, Fatih Haşlak, Sezgin Şahin, Oya Köker, Aybüke Günalp, Kenan Barut, Özgür Kasapçopur

DOI: 10.46497/ArchRheumatol.2023.9636

Issue: Volume 38 - Issue 2 - June 2023
2377 1800

Progressive pulmonary fibrosis in patients with connective tissue disease-associated interstitial lung disease: An explorative study

Jakob Höppner, Maximilian Wollsching-Strobel, Falk Schumacher, Wolfram Windisch, Melanie Berger

DOI: 10.46497/ArchRheumatol.2024.10105

Issue: Volume 39 - Issue 1 - March 2024
3039 1822

Predictive risk factors for one-year mortality in idiopathic inflammatory myopathy patients with interstitial lung disease: A retrospective, single-center cohort study

Minna Jiang, Xiaohong Wen, Sisi Xia, Yiqun Guo, Yu Bai

DOI: 10.46497/ArchRheumatol.2024.10418

Issue: Volume 39 - Issue 2 - June 2024
2315 1461

Rituximab for rheumatoid arthritis-related interstitial lung disease: A systematic review and meta-analysis

Tarun Krishna Boppana, Saurabh Mittal, Karan Madan, Anant Mohan, Vijay Hadda, Randeep Guleria

DOI: 10.46497/ArchRheumatol.2024.10199

Issue: Volume 39 - Issue 2 - June 2024
11099 3320

Lung involvement in patients with psoriatic arthritis

Mehmet Hünür, Tahir Saygın Öğüt, Ece Çelik, Funda Erbasan, Melis Dilbil, Mine Nokay, Mustafa Ender Terzioğlu, Veli Yazisiz

DOI: 10.46497/ArchRheumatol.2024.10537

Issue: Volume 39 - Issue 4 - December 2024
3907 1512

Association of Health-Related Quality of Life with Functional and Radiological Outcomes in Patients with Rheumatoid Arthritis–Associated Interstitial Lung Disease, Systemic Sclerosis–Associated Interstitial Lung Disease, and Idiopathic Pulmonary Fibrosis

Irem Sahinoğlu, Deniz Kizilirmak, Sadettin Uslu, Mevlüt Kacar, Filiz Cemre Tasgöz, Seref Sülükcü, Emre Ali Acar, Müge Gencer Tuluy, Secil Sari, Ozgül Soysal Gündüz, Timur Pirildar

DOI: 10.5152/ArchRheumatol.2025.11105

Issue: Volume 40 - Issue 3 - September 2025
739 107

Correlation of Pleural and Pulmonary Ultrasound with the Severity of Autoimmune Interstitial Lung Disease

Luis Javier Cajas Santana, Satiago Cuero, Gabriela Guerrero, Mayelin Ceballos, María Carolina Torres Villarreal

DOI: 10.5152/ArchRheumatol.2025.10999

Issue: Volume 40 - Issue 3 - September 2025
707 84

Treatment of Systemic Sclerosis-Associated Interstitial Lung Disease: A Systematic Review and Network Meta-Analysis

Siyao Wu, Wanling Xu, Zhen Bei, Junpei Wu, Mingchun Zhang

DOI: 10.5152/ArchRheumatol.2025.25013

Issue: Volume 40 - Issue 3 - September 2025
109 118